Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Alberta

$9,966.00

Wireless, implantable neural interface technologies

EF 2012-13

Résumé
Neural interfaces (NIs) are devices that interface with the peripheral or central nervous system, for example the brain, peripheral nerves, or the spinal cord, and detect, record and/or stimulate neural activity to restore function lost to neural injury or disease. For example, we have been developing the technique of intraspinal microstimulation (ISMS) for restoring standing and walking and have successfully restored standing and walking function in the cat model for walking. However, NPs require large amounts of data processing; neural activity must be detected, recorded and processed; predictions of body position, joint trajectories, and muscular forces are calculated; then numerous, complex signals are sent back to the brain, nerves, and/or spinal cord. All of this must happen in fractions of a second to generate smooth, natural walking, for example. Current technology is not practical for real-world NI/NP applications; processing is supplied by large units that are tethered to the subject by cables and wires. For NIs and NPs to become usable, data processing and communication technologies must be developed that have ultra-low power requirements, and are of the microelectronic scale so as to be suitable for implantation. Such technologies are not currently available. We are developing platform technologies for in vivo neural recording, neural data processing and compression, and wireless data transmission to enable NIs. Prototypes of these technologies have been built, tested and validated. The proposed study will not only examine the market needs for NI applications but also explore other applications with lower market entry barriers (for example lower regulatory requirements). It will provide valuable insight into the design requirements of this technology to meet the needs of potential consumers. Furthermore, the proposed market assessment will form the basis of a commercialization plan and will allow us to have an informed discussion as to what model of commercialization should be used for this technology (licensing versus start-up creation).
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
435032-2012
Name nom
Mushahwar, Vivian
Department département
Cell Biology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
9966
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Wireless, implantable neural interface technologies
Keyword
NSERC
Application summary
Neural interfaces (NIs) are devices that interface with the peripheral or central nervous system, for example the brain, peripheral nerves, or the spinal cord, and detect, record and/or stimulate neural activity to restore function lost to neural injury or disease. For example, we have been developing the technique of intraspinal microstimulation (ISMS) for restoring standing and walking and have successfully restored standing and walking function in the cat model for walking. However, NPs require large amounts of data processing; neural activity must be detected, recorded and processed; predictions of body position, joint trajectories, and muscular forces are calculated; then numerous, complex signals are sent back to the brain, nerves, and/or spinal cord. All of this must happen in fractions of a second to generate smooth, natural walking, for example. Current technology is not practical for real-world NI/NP applications; processing is supplied by large units that are tethered to the subject by cables and wires. For NIs and NPs to become usable, data processing and communication technologies must be developed that have ultra-low power requirements, and are of the microelectronic scale so as to be suitable for implantation. Such technologies are not currently available. We are developing platform technologies for in vivo neural recording, neural data processing and compression, and wireless data transmission to enable NIs. Prototypes of these technologies have been built, tested and validated. The proposed study will not only examine the market needs for NI applications but also explore other applications with lower market entry barriers (for example lower regulatory requirements). It will provide valuable insight into the design requirements of this technology to meet the needs of potential consumers. Furthermore, the proposed market assessment will form the basis of a commercialization plan and will allow us to have an informed discussion as to what model of commercialization should be used for this technology (licensing versus start-up creation).